Open an account

CapForce IBD Breakout Opportunities ETF

BOUT · ETF

$42.45+$0.2975 (+0.71%)TodayMarket closed ·
Prev close $42.16

About BOUT

BOUT was created on 2018-09-13 by CapForce. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 14.97m in AUM and 27 holdings. BOUT tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors. The fund may hold 50% T-bills based on technical market signals.

Issuer
CapForce
Tracks
IBD Breakout Stocks Total Return
Expense ratio
0.8%
Assets under management
$14.90M
Inception
Sep 13, 2018
Asset class
Equity
Website
capforceetf.com

BOUT key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
1.39K
Volume
1.36K
Open price
$42.21
High today
$42.52
Low today
$42.39
52 Week high
$49.41
52 Week low
$40.63

CapForce IBD Breakout Opportunities ETF (BOUT) at a glance

As of Oct 23, 2026, CapForce IBD Breakout Opportunities ETF (BOUT) shares are priced at $42.45, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $42.39 and $42.52. The current price is 0.1% above the day's low and 0.1% below its high.

Volume so far is 1.36K shares, in line with the average of 1.39K shares a day.

Over the past year CapForce IBD Breakout Opportunities ETF has ranged from $40.63 to $49.41, and now sits 21% of the way up that range.

BOUT news

  • Chandrima Sanyal

    Smart Beta Meets IBD: CapForce Rebrands Innovator's IBD Funds In Rules-Based Push

  • Press releaseBusiness Wire

    Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform

  • Press releaseBusiness Wire

    Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs

  • Press releaseGlobe Newswire

    Innovator Announces Results of Special Meeting of Shareholders Relating to the Reorganizations of Innovator IBD® Breakout Opportunities ETF and Innovator IBD® 50 ETF

  • Lekha Gupta

    GEO Missed Q1 Targets On Rising Costs And Debt, Guides Q2 Below Street Estimates

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.